TNFSF10 and prostate carcinoma: In addition, in prostate cancer cell lines resistant to TRAIL, incubation with the chemotherapy drug, decitabine, sensitises these cells to TRAIL-mediated apoptosis, partly through a reduction in anti-apoptotic proteins including PEA-15 (Festuccia et al., 2008).